Medicamen Biotech Ltd Q2 FY2023-2024 Results: Summary
Revenue | ₹44.09Cr |
Net Profits | ₹1.51Cr |
Net Profit Margins | 3.42% |
Highlights
Revenue:
Medicamen Biotech Ltd’s revenue jumped 29.45% since last year same period to ₹44.09Cr in the Q2 2023-2024. On a quarterly growth basis, Medicamen Biotech Ltd has generated 4.18% jump in its revenue since last 3-months.
Net Profits:
Medicamen Biotech Ltd’s net profit fell -58.06% since last year same period to ₹1.51Cr in the Q2 2023-2024. On a quarterly growth basis, Medicamen Biotech Ltd has generated -63.88% fall in its net profits since last 3-months.
Net Profit Margins:
Medicamen Biotech Ltd’s net profit margin fell -67.6% since last year same period to 3.42% in the Q2 2023-2024. On a quarterly growth basis, Medicamen Biotech Ltd has generated -65.33% fall in its net profit margins since last 3-months.
